26 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
and Secretary, in consideration for an annualized salary of $410,000. The Employment Agreement provides for a signing bonus of $56,666.00. The Employment … Agreement contemplates an annual cash bonus, as determined by the Board in its sole discretion and in good faith. The target cash bonus is 50% of Mr
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
and Secretary, in consideration for an annualized salary of $410,000. The Employment Agreement provides for a signing bonus of $56,666.00. The Employment … Agreement contemplates an annual cash bonus, as determined by the Board in its sole discretion and in good faith. The target cash bonus is 50% of Mr
10-Q
2024 Q1
EX-10.3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
.
Signing Bonus. Executive shall be paid a signing bonus of $56,666.00 (the “Signing Bonus”), less applicable taxes and withholdings, representing … for the period from January 1, 2024 through April 30, 2024. The Signing Bonus shall be paid within ten (10) days of the Effective Date and only
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
Agreement provides for a signing bonus of $56,666.00. The Employment Agreement contemplates an annual cash bonus, as determined by the Board in its … sole discretion and in good faith. The target cash bonus is 50% of Mr. Knuettel’s annualized salary and will be based on achievement of performance
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
-based compensation awards and cash-based performance bonus awards.
In addition, we have a three person Scientific Advisory Board led by Dr. Stephen … Bonus Shares (as defined below), received by holders of the senior secured convertible notes upon conversion of such notes.
In connection with our
424B3
k69k 7is26pgvbdmdtp
16 Apr 24
Prospectus supplement
5:45pm
10-K
EX-97.1
wlm4g23xe9ht
16 Apr 24
Annual report
4:48pm
10-K
lec78831t8thl
16 Apr 24
Annual report
4:48pm
8-K
EX-1.1
ju4 1v9mw
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
6rq z6u77hj8te6yif
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
7ugjdg7m qc6cuda
20 Feb 24
Prospectus supplement with pricing info
5:28pm